In addition, the mammalian target of rapamycin (mTOR) seems to play a significant role in the metabolic reprogramming of tumor cells, specifically mTOR complex 1 (mTORC1), which is activated in the majority of cancers [19]. This evidence concerns the gene MTOR and cancer.